Zoetis will also introduce new ambitions for the four tenets of its long-standing value proposition over the next 3-5 years, including: Based on our track record and talented colleagues, we are confident in our ability to broaden our existing billion-dollar franchises, while innovating and building new ones through continued investments in R&D, supply chain and commercial excellence,” said Peck. “We pride ourselves on shaping animal health and creating new markets based on game-changing innovations. “Our growth and value creation is rooted in the right strategy, a diverse portfolio, our leadership in innovation, and global capabilities that allow us to capitalize on the opportunities we see in an attractive Animal Health market,” said Kristin Peck, Chief Executive Officer of Zoetis. Zoetis will also provide an update on its R&D pipeline and future growth opportunities in new therapies for renal disease, cardiology and oncology, as well as its livestock and diagnostics portfolios. The executive team will discuss its strategy for expanding its current billion-dollar franchises in dermatology and pet parasiticides, and new expectations for its osteoarthritis pain franchise to reach more than $1 billion in peak sales. Zoetis sees long-term sustainable growth driven by new products and lifecycle innovations for companion animals and livestock.

Investing in capabilities and innovation that differentiate Zoetis.Ĭontinuing to create value for shareholders through revenue growth, strategic investments, margin expansion and capital return. ET today at the New York Stock Exchange, where the company will dive into its compelling growth ambitions, its innovative and robust R&D pipeline and its financial roadmap to continue delivering shareholder value, as it Shapes Animal Health for the Next Decade.ĭuring today’s presentations, Chief Executive Officer Kristin Peck, Chief Financial Officer Wetteny Joseph, President of Research & Development Robert Polzer, Ph.D., and other members of the Zoetis executive team will outline the company’s plans to deliver on its ambitions by:īuilding on its leadership in Animal Health to shape and expand the future of animal care.ĭelivering growth in a dynamic and resilient industry by innovating and growing faster than the market.ĭriving its next phase of game-changing franchises through internal R&D and business development.

(NYSE:ZTS) is hosting an investor day at 9:00 a.m. PARSIPPANY, N.J.-(BUSINESS WIRE)- Zoetis Inc.

Zoeti download the new version for mac